Amy Dai
Amy Dai is a Shanghai-based partner with Global Law Office. Amy Dai has rich experience providing legal services for fund formation and PE/VC investment. She has advised on more than 30 fund formation projects, including pure RMB Fund, JV Fund and USD Fund. She has also helped many domestic and international funds to invest in China through various structures across industrials such as life science, medical and pharmaceutical, health care, telecommunications, new energy, semi-conductor etc. In addition, Amy Dai has helped several issuers in their initial public offering on both the international stock exchanges such as Nasdaq, AIM, Hong Kong Stock Exchange, and Taiwan stock exchange. Amy Dai worked for Boehringer Ingelheim (China), a top fifteen multinational pharmaceutical company, as the legal counsel in 2009 and 2010. · Global Law Office
About
Amy Dai is a Shanghai-based partner at Global Law Office who specialises in fund formation and PE/VC investment, having advised on more than 30 fund formation projects (including pure RMB funds, JV funds and USD funds). She has assisted domestic and international funds investing in China across multiple industries and has supported issuers on initial public offerings on exchanges including Nasdaq, AIM, Hong Kong Stock Exchange and the Taiwan Stock Exchange; she previously worked as legal counsel for Boehringer Ingelheim (China) in 2009–2010.
Practice areas
Office
Expertise
Education
- Peking University, Law School (2004–2007)
- Fudan University, Journalism School (2000–2004)
Admissions
- PRC (admitted 2008)